ProtexAging: ProtexAging – New modeling compounds for the treatment of aging-associated diseases (Q2866755): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Removed claim: co-financing rate (P837): 76.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 76.0 percent / rank | |||||||
Revision as of 09:59, 13 September 2021
Project Q2866755 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ProtexAging: ProtexAging – New modeling compounds for the treatment of aging-associated diseases |
Project Q2866755 in Portugal |
Statements
6,295.53 Euro
0 references
24 January 2020
0 references
23 January 2022
0 references
UNIVERSIDADE DE COIMBRA
0 references
Q2988597 (Deleted Item)
0 references
40°12'40.28"N, 8°25'46.06"W
0 references
Pretende-se promover a transferência do conhecimento valorizando recursos que podem ser transformados em produtos inovadores e de elevado valor acrescentado para novas terapêuticas para doenças associadas ao envelhecimento, através da proteção da tecnologia por pedido de patente. (Portuguese)
0 references
The aim is to promote the transfer of knowledge by valuing resources that can be transformed into innovative and high added value products for new therapies for diseases associated with ageing, through the protection of technology by patent application. (English)
7 July 2021
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0145-FEDER-046792
0 references